A Phase II Randomized, Double-Blind, Placebo-Controlled Experiment to See How a GABAA-α5 NAM (basmisanil) Affects Intellectual Impairment in People With Down Syndrome
Physician's Weekly,
For a study, it was determined that there were no pharmaceutical treatments available to help people with Down syndrome who had…